LGM

Logos Global Management Portfolio holdings

AUM $749M
This Quarter Return
+0.03%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$970M
AUM Growth
+$970M
Cap. Flow
-$201M
Cap. Flow %
-20.76%
Top 10 Hldgs %
49.08%
Holding
83
New
26
Increased
6
Reduced
23
Closed
17

Top Buys

1
VTYX icon
Ventyx Biosciences
VTYX
$36.2M
2
RPTX icon
Repare Therapeutics
RPTX
$35.4M
3
GBT
Global Blood Therapeutics, Inc.
GBT
$22M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$21.7M
5
CYTK icon
Cytokinetics
CYTK
$14.8M

Top Sells

1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$62.9M
2
KZR icon
Kezar Life Sciences
KZR
$44.3M
3
PMVP icon
PMV Pharmaceuticals
PMVP
$41.7M
4
BCYC
Bicycle Therapeutics
BCYC
$36.8M
5
NKTX icon
Nkarta
NKTX
$35.5M

Sector Composition

1 Healthcare 99.83%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PYXS icon
51
Pyxis Oncology
PYXS
$91.2M
$3.14M 0.32%
+286,652
New +$3.14M
TVTX icon
52
Travere Therapeutics
TVTX
$1.75B
$3.1M 0.32%
+100,000
New +$3.1M
NUVL icon
53
Nuvalent
NUVL
$5.74B
$2.56M 0.26%
134,650
– –
LIAN
54
DELISTED
LianBio American Depositary Shares
LIAN
$2.54M 0.26%
+412,837
New +$2.54M
WVE icon
55
Wave Life Sciences
WVE
$1.27B
$2.51M 0.26%
+800,000
New +$2.51M
SLGC
56
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.33M 0.24%
200,493
– –
BMEA icon
57
Biomea Fusion
BMEA
$114M
$1.88M 0.19%
252,320
-450,000
-64% -$3.35M
MRNS
58
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.54M 0.16%
+130,000
New +$1.54M
VERA icon
59
Vera Therapeutics
VERA
$1.47B
$1.34M 0.14%
+50,000
New +$1.34M
COGT icon
60
Cogent Biosciences
COGT
$1.83B
$1.29M 0.13%
150,000
-775,000
-84% -$6.65M
OMGA
61
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$999K 0.1%
88,235
– –
VRNA
62
Verona Pharma
VRNA
$9.18B
$820K 0.08%
+122,000
New +$820K
DAWN icon
63
Day One Biopharmaceuticals
DAWN
$766M
$624K 0.06%
37,069
-15,000
-29% -$253K
IVVD icon
64
Invivyd
IVVD
$218M
$508K 0.05%
+70,000
New +$508K
NUVB.WS icon
65
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$126K 0.01%
66,666
– –
MREO
66
Mereo BioPharma
MREO
$275M
$75K 0.01%
46,984
– –
ALT icon
67
Altimmune
ALT
$325M
– –
-700,000
Closed -$7.92M
GHRS icon
68
GH Research
GHRS
$870M
– –
-324,333
Closed -$6.44M
GLUE icon
69
Monte Rosa Therapeutics
GLUE
$309M
– –
-50,000
Closed -$1.11M
IOVA icon
70
Iovance Biotherapeutics
IOVA
$800M
– –
-500,000
Closed -$12.3M
KROS icon
71
Keros Therapeutics
KROS
$638M
– –
-15,000
Closed -$593K
NKTX icon
72
Nkarta
NKTX
$149M
– –
-1,275,777
Closed -$35.5M
PASG icon
73
Passage Bio
PASG
$22.6M
– –
-6,251
Closed -$1.25M
PMVP icon
74
PMV Pharmaceuticals
PMVP
$82.1M
– –
-1,400,000
Closed -$41.7M
PRLD icon
75
Prelude Therapeutics
PRLD
$69.1M
– –
-400,000
Closed -$12.5M
1 2
3
4